SCHEMBL16809059

SCHEMBL16809059

CCCCOC[C@H]1OC(O)(c2ccc(OCCCC)nc2C)C(OCCCC)[C@H]1OCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17082397 1.00 — —
SCHEMBL18081771 0.89 — —
SCHEMBL17751302 0.89 — —
SCHEMBL18081854 0.84 — —
SCHEMBL16631697 0.84 — —
SCHEMBL17082395 0.81 MEN1 (0.33) —
SCHEMBL16631945 0.81 MEN1 (0.33) —
SCHEMBL16631654 0.79 — —
SCHEMBL18081987 0.78 RARA (0.33) —
SCHEMBL18081840 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170175129-A1 ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF MODERNA THERAPEUTICS INC (US) 2017-06-22 — — US disclosed
US-20160264614-A1 POLYNUCLEOTIDE MOLECULES AND USES THEREOF MODERNA THERAPEUTICS, INC. (US) 2016-09-15 — — US disclosed
US-20150167017-A1 ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF MODERNA THERAPEUTICS, INC. 2015-06-18 — — US disclosed
Send feedback